Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?

The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors

Peters, A. L., & Schriger, D. L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00206-x · Cited by 32

Dietary Fish Oil and Insulin Action in Humans

Heine, R. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35698.x · Cited by 29

Diabetic dyslipidaemia

Durrington, P. N. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0019 · Cited by 31

Type 2 Diabetes Mellitus in Augsburg - an Epidemiological Overview

Meisinger, C., Döring, A., Heier, M., Thorand, B., & Löwel, H. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858251 · Cited by 30

Prediabetes: To treat or not to treat?

Moutzouri, E., Tsimihodimos, V., Rizos, E. C., & Elisaf, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.007 · Cited by 31

Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT)

Koopman, R. J., Mainous, A. G., Everett, C. J., & Carter, R. E. (2008) · The Annals of Family Medicine · doi:10.1370/afm.913 · Cited by 35

Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile

Andreozzi, F., Mannino, G. C., Perticone, M., Perticone, F., & Sesti, G. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.020 · Cited by 30

Hyperglycemia, Hyperinsulinemia, Overweight, and High Blood Pressure in Young Adults

Pozzan, R., Brandão, A. A., da Silva, S. L. D., & Brandão, A. P. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.650 · Cited by 28

Impaired glucose tolerance and type 2 diabetes mellitus: a new field for pediatrics in Europe

Wiegand, S., Dannemann, A., Krude, H., & Grüters, A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803081 · Cited by 29

Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease

Martens, F. M. A. C., van der Graaf, Y., Dijk, J. M., Olijhoek, J. K., & Visseren, F. L. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.02.019 · Cited by 29

Silent myocardial infarction in women with impaired glucose tolerance: The Northern Sweden MONICA study

Lundblad, D., & Eliasson, M. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-9 · Cited by 29

Peroxisome Proliferator-Activated Receptor Gamma Agonists: Their Role as Vasoprotective Agents in Diabetes

Blaschke, F., Caglayan, E., & Hsueh, W. A. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.001 · Cited by 30

Cardiovascular Risk Factors and the Prediabetic Syndrome

Haffner, S. M. (1996) · Annals of Medicine · doi:10.3109/07853899608999094 · Cited by 28

Differential Association Between HDL Subclasses and the Development of Type 2 Diabetes in a Prospective Study of Japanese Americans

Hwang, Y., Hayashi, T., Fujimoto, W. Y., Kahn, S. E., Leonetti, D. L., McNeely, M. J., & Boyko, E. J. (2015) · Diabetes Care · doi:10.2337/dc15-0625 · Cited by 29

Potential National and State Medical Care Savings From Primary Disease Prevention

Ormond, B. A., Spillman, B. C., Waidmann, T., Caswell, K. J., & Tereshchenko, B. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.182287 · Cited by 28

Cardiovascular risk assessment in metabolic syndrome: view from PROCAM

Assmann, G., Nofer, J., & Schulte, H. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.017 · Cited by 29

Issues Surrounding Tight Glycemic Control in People with Type 2 Diabetes Mellitus

Cerveny, J. D., Leder, R. D., & Weart, C. W. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17375 · Cited by 27

Involvement of the Pancreatic Renin‐Angiotensin System in Insulin Resistance and the Metabolic Syndrome

Leung, P. S., & de Gasparo, M. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05460.x · Cited by 28

The change in motivating factors influencing commencement, adherence and retention to a supervised resistance training programme in previously sedentary post-menopausal women: a prospective cohort study

Viljoen, J. E., & Christie, C. J.-A. (2015) · BMC Public Health · doi:10.1186/s12889-015-1543-6 · Cited by 25

Relationship between serum apolipoproteins levels and retinopathy risk in subjects with type 2 diabetes mellitus

Zhang, Q., Hu, J.-E., Hu, Y., Ding, Y., Zhu, J., & Zhuang, C. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1136-9 · Cited by 27

Atherogenesis and Diabetes: Focus on Insulin Resistance and Hyperinsulinemia

Madonna, R., & Caterina, R. D. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.11.009 · Cited by 27

Aterogénesis y diabetes: resistencia a la insulina e hiperinsulinemia

Madonna, R., & Caterina, R. D. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.11.010 · Cited by 27

Vascular Complications of Diabetes Mellitus

Chiong, Y., & Evans‐Molina, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-37078-6_49 · Cited by 28

A family history of Type 2 diabetes is associated with increased plasma levels of C‐reactive protein in non‐smoking healthy adult women

Pannacciulli, N., Pergola, G. D., Giorgino, F., & GIORGINO, R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00770.x · Cited by 27

Biomarkers of insulin sensitivity/resistance

Kosmas, C. E., Sourlas, A., Oikonomakis, K., Zoumi, E.-A., Papadimitriou, A., & Kostara, C. E. (2024) · Journal of International Medical Research · doi:10.1177/03000605241285550 · Cited by 31

Diminution of early insulin response to glucose in subjects with normal but minimally elevated fasting plasma glucose. Evidence for early β‐cell dysfunction

Sato, Y., Komatsu, M., Katakura, M., Ohfusa, H., Yamada, S., Yamauchi, K., Hiramatsu, K., Ichikawa, K., Aizawa, T., & Hashizume, K. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00746.x · Cited by 26

Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study–74)

Anuradha, S., Mohan, V., Gokulakrishnan, K., & Dixit, M. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.022 · Cited by 26

Multivariate epidemiologic analysis of type 2 diabetes mellitus risks in the Lebanese population

Ghassibe‐Sabbagh, M., Deeb, M. E., Salloum, A. K., Mouzaya, F., Haber, M., Al-Sarraj, Y. A., Chami, Y. G., Akle, Y., Hirbli, K., Nemr, R., et al. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-89 · Cited by 26

Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis

Laichuthai, N., Abdul‐Ghani, M. A., Kosiborod, M., Parksook, W. W., Kerr, S. J., & DeFronzo, R. A. (2020) · Diabetes Care · doi:10.2337/dc20-0059 · Cited by 38

Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertension

Francis, B. H., Song, X., Andrews, L. M., Purkayastha, D., Princic, N., Sedgley, R., & Rudolph, A. E. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.554806 · Cited by 26

Incident Hyperglycaemia among Older Adults with or At-Risk for HIV Infection

Polsky, S., Floris-Moore, M., Schoenbaum, E. E., Klein, R. S., Arnsten, J. H., & Howard, A. A. (2010) · Antiviral Therapy · doi:10.3851/imp1711 · Cited by 26

Doença cardiovascular no diabetes mellitus: análise dos fatores de risco clássicos e não-clássicos

Siqueira, A. F. A., de Almeida-Pititto, B., & Ferreira, S. R. G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000200014 · Cited by 27

Quality of life and diabetes

Rubin, R. R., & Peyrot, M. F. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199905/06)15:3 · Cited by 1,147

Syndrome X: Is one enough?

Reaven, G. M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90073-6 · Cited by 26

Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry

Valabhji, J., & Elkeles, R. S. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030030501 · Cited by 25

Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion

Nilsson, O., Giudice, R. D., Nagao, M., Grönberg, C., Eliasson, L., & Lagerstedt, J. O. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165613 · Cited by 25

Coronary Artery Calcification and Its Relationship to Validated Genetic Variants for Diabetes Mellitus Assessed in the Heinz Nixdorf Recall Cohort

Pechlivanis, S., Scherag, A., Mühleisen, T. W., Möhlenkamp, S., Horsthemke, B., Boes, T., Bröcker‐Preuß, M., Mann, K., Erbel, R. M., Jöckel, K., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.208496 · Cited by 27

Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees

Hu, Y., Ren, Y., Luo, R. Z.-T., Mao, X., Li, X., Cao, X., Guan, L., Chen, X., Li, J., Long, Y., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600382-jlr200 · Cited by 25

Nutrition and coronary heart disease

Hankey, C. R., & Leslie, W. S. (2001) · Coronary Health Care · doi:10.1054/chec.2001.0143 · Cited by 25

Epidemiology of Macrovascular Disease and Hypertension in Diabetes Mellitus

Tuomilehto, J. O., Rastenytė, D., Qiao, Q., & Jakovljević, D. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1002 · Cited by 25

The kidney in non-insulin-dependent diabetes

Schmitz, A. (1992) · Acta Diabetologica · doi:10.1007/bf00572545 · Cited by 25

2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis

Gyldenkerne, C., Kahlert, J. A., Thrane, P. G., Olesen, K. K. W., Mortensen, M. B., Sørensen, H. T., Thomsen, R. W., & Mæng, M. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.050 · Cited by 30

Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes

Matikainen, N., & Taskinen, M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0309-3 · Cited by 24

Glutamine enhances the heat shock protein 70 expression as a cardioprotective mechanism in left heart tissues in the presence of diabetes mellitus

Uğurlucan, M., Erer, D., Karatepe, O., Ziyade, S., Haholu, A., Uğurlucan, F. G., Filizcan, U., Tirelı, E., Dayıoğlu, E., & Alpagut, U. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.521500 · Cited by 24

Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet

Diamond, D. M., Bikman, B. T., & Mason, P. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000764 · Cited by 27

Insulin Resistance: Concepts, Controversies, and the Role of Nutrition

Sievenpiper, J. L., Jenkins, A. L., Whitham, D., & Vuksan, V. V. V. (2002) · Canadian Journal of Dietetic Practice and Research · doi:10.3148/63.1.2002.20 · Cited by 24

Lipid management in patients with diabetes mellitus.

Brown, A. S. (2005) · American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.001 · Cited by 26

The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction

Dirkali, A., van der Ploeg, T., Nangrahary, M., Cornel, J. H., & Umans, V. A. W. M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.08.107 · Cited by 24

Managing diabetic dyslipidemia: Beyond statin therapy

Neeli, H., Gadi, R., & Rader, D. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0004-y · Cited by 22

Type 2 diabetes mellitus: ‘the silent killer’

Campbell, I. W. (2001) · Practical Diabetes · doi:10.1002/pdi.230 · Cited by 28

Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients—a review

Schmitz, A. (1993) · Diabetologia · doi:10.1007/bf02374488 · Cited by 24

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

Hashemi Madani, N., Ismail-Beigi, F., Poustchi, H., Nalini, M., Sepanlou, S. G., Malek, M., Abbasi, M. A., Khajavi, A., Khamseh, M. E., & Malekzadeh, R. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01390-8 · Cited by 22

Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function

Hodson, A. E., Tippetts, T. S., & Bikman, B. T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0316-y · Cited by 25

The Atherogenic Index Log (Triglyceride/HDL-Cholesterol) as a Biomarker to Identify Type 2 Diabetes Patients with Poor Glycemic Control

Nosrati, M., Safari, M., Alizadeh, A., Ahmadi, M., & Mahrooz, A. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_357_20 · Cited by 23

Insulin resistance, haemostatic factors and cardiovascular risk

Mills, J. D., & Grant, P. J. (2002) · The British Journal of Diabetes · doi:10.1177/14746514020020011301 · Cited by 23

When Does New Onset Diabetes Resulting From Antihypertensive Therapy Increase Cardiovascular Risk

Bakris, G. L., & Sowers, J. R. (2004) · Hypertension · doi:10.1161/01.hyp.0000125727.92964.e2 · Cited by 23

Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program

Goldberg, R. B., Temprosa, M., Mele, L., Orchard, T., Mather, K., Bray, G., Horton, E., Kitabchi, A., Krakoff, J., Marcovina, S., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2015.11.011 · Cited by 22

Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers

Edlund, A. K., Chen, K., Lee, W., Protas, H. D., Su, Y., Reiman, E. M., Caselli, R. J., & Nielsen, H. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210065 · Cited by 22

Exercise attenuates the premature cardiovascular aging effects of type 2 diabetes mellitus

Huebschmann, A. G., Kohrt, W. M., & Regensteiner, J. G. (2011) · Vascular Medicine · doi:10.1177/1358863x11419996 · Cited by 22

Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m2

Ke, Z., Li, F., Chen, J., Gao, Y., Zhou, X., Sun, F., Li, C., Liu, B., Li, Q., Zhu, Z., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2926-9 · Cited by 22

Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i

Lamacchia, O., & Sorrentino, M. R. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200317150359 · Cited by 22

Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation

Diakakis, G., PARTHENAKIS, F. I., Patrianakos, A. P., Koukouraki, S., Stathaki, M. I., Karkavitsas, N. S., & Vardas, P. E. (2007) · Cardiovascular Pathology · doi:10.1016/j.carpath.2007.07.007 · Cited by 22

Insulin resistance and cardiovascular disease: the role of PPARγ activators beyond their anti-diabetic action

Walcher, D., & Marx, N. (2004) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2004.011 · Cited by 22

Diabetes and the metabolic syndrome—When is it best to intervene to prevent?

Haffner, S. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.002 · Cited by 22

Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: Flow-mediated Dilation Japan (FMD-J) study

Yamaji, T., Harada, T., Hashimoto, Y., Takaeko, Y., Kajikawa, M., Kihara, Y., Hida, E., Chayama, K., Goto, C., Han, Y., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001610 · Cited by 21

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No

Kassem, S., & Raz, I. (2009) · Diabetes Care · doi:10.2337/dc09-s335 · Cited by 21

Glycated albumin in diabetes mellitus: a meta-analysis of diagnostic test accuracy

Chume, F. C., Freitas, P. A. C., Schiavenin, L. G., Pimentel, A. L., & Camargo, J. L. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0105 · Cited by 21

Rationale for New American Diabetes Association Guidelines: Are National Cholesterol Education Program Goals Adequate for the Patient with Diabetes Mellitus?

Haffner, S. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.05.012 · Cited by 21

Arterial stiffness and endothelial inflammation in prediabetes and newly diagnosed diabetes patients

Çakar, M., Balta, Ş., Şarlak, H., Akhan, M., Demırkol, S., Karaman, M., Ay, S. A., Kurt, Ö., Çaycı, T., İnal, S., et al. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000061 · Cited by 21

Should the Insulin Resistance Syndrome be Treated in the Elderly?

Grant, R. W., & Meigs, J. B. (2004) · Drugs & Aging · doi:10.2165/00002512-200421030-00001 · Cited by 21

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients

Vlek, A. L. M., van der Graaf, Y., Spiering, W., Visseren, F. L. J., & SMART study group (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.5 · Cited by 21

PREVENTION OF TYPE 2 DIABETES

Goldberg, R. B. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70025-0 · Cited by 21

Lipoprotein response to exercise training and a low-fat diet in older subjects with glucose intolerance

Hughes, V., Fiatarone, M., Ferrara, C., McNamara, J., Charnley, J., & Evans, W. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.820 · Cited by 20

Hyperbaric Oxygen Therapy and Vascular Complications in Diabetes Mellitus

Resanović, I., Zarić, B. L., Radovanović, J., Sudar-Milovanovic, E. M., Gluvic, Z. M., Jevremović, D., & Isenović, E. R. (2020) · Angiology · doi:10.1177/0003319720936925 · Cited by 20

Cell‐specific insulin resistance: implications for atherosclerosis

Rajwani, A., Cubbon, R. M., & Wheatcroft, S. B. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2336 · Cited by 20

Is Management of Central Retinal Artery Occlusion the Next Frontier in Cerebrovascular Diseases?

Limaye, K. S., Wall, M., Uwaydat, S. H., Ali, S., Shaban, A., Kasab, S. A., & Adams, H. P. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.06.006 · Cited by 20

Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction

Shah, B., Amoroso, N. S., & Sedlis, S. P. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31822fb423 · Cited by 20

Glycaemic Profiles of Children With Overweight and Obesity in Free-living Conditions in Association With Cardiometabolic Risk

Rijks, J. H. J., Karnebeek, K., van Dijk, J., Dorenbos, E., Gerver, W. M., Stouthart, P. J. H. M., Plat, J., & Vreugdenhil, A. C. E. (2016) · Scientific Reports · doi:10.1038/srep31892 · Cited by 20

Diabetes: Statins, fibrates, or both?

Farnier, M., & Picard, S. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0006-y · Cited by 20

Metabolic safety of antihypertensive drugs: Myth versus reality

Stas, S. N., Appesh, L., & Sowers, J. R. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0086-8 · Cited by 19

The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue

Sprenkle, N. T., Winn, N. C., Bunn, K. E., Zhao, Y., Park, D. J., Giese, B. G., Karijolich, J. J., Ansel, K. M., Serezani, C. H., Hasty, A. H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112928 · Cited by 19

Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians

Nair, A. K., Piaggi, P., McLean, N. A., Kaur, M., Kobes, S., Knowler, W. C., Bogardus, C., Hanson, R. L., & Baier, L. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3835-x · Cited by 19

Adipocyte-endothelial cell interplay in adipose tissue physiology

Chaurasiya, V., Haridas, P. A. N., & Olkkonen, V. M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116081 · Cited by 20

Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment

Steylen, P., der Heijden, F. M. M. A. V., Kok, H., Sijben, N., & Verhoeven, W. M. A. (2013) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2013.779000 · Cited by 17

Metabolic syndrome, inflammation and atherothrombosis

Weiss, T. W., & Rohla, M. (2013) · Hämostaseologie · doi:10.5482/hamo-13-07-0035 · Cited by 18

Prevalence of Cardiovascular Risk Factors in the Balearic Islands (CORSAIB Study)

Carratalà, F. R., Juan, G. F., Cànaves, J. L., Ruiz, T. R., Bosch, I. B., & Fuentespina, E. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60748-2 · Cited by 18

Effects of macronutrient excess and composition on oxidative stress: Relevance to diabetes and cardiovascular disease

Ceriello, A. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0022-z · Cited by 18

Microalbuminuria: do we need a new threshold?

Zamora, C. R. A., & Cubeddu, L. X. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.105 · Cited by 18

Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective

Cubbon, R. M., Kahn, M., & Kearney, M. T. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01646.x · Cited by 18

Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension

Lim, H. S., Lip, G. Y. H., Beevers, D. G., & Blann, A. D. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01495.x · Cited by 18

The effects of metformin on cardiovascular risk factors

Grant, P. J. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110507 · Cited by 18

Cardiovascular disease prevention in primary care

Chauhan, U. (2007) · British Medical Bulletin · doi:10.1093/bmb/ldm002 · Cited by 17

The metabolic syndrome: an Asian perspective

Tan, C.-E., Chew, S., & Tai, E. S. (2004) · International Congress Series · doi:10.1016/j.ics.2003.12.089 · Cited by 17

Acarbose improves fibrinolytic activity in patients with impaired glucose tolerance

Shinoda, Y., Inoue, I., Nakano, T., Seo, M., Sassa, M., Goto, S.-I., Awata, T., Komoda, T., & Katayama, S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.023 · Cited by 17

Mitogenic factors accelerate later-age diseases: insulin as a paradigm

Lev-Ran, A. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00027-x · Cited by 17

Progress in Population Analyses of the Insulin Resistance Syndrome

Haffner, S. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51818.x · Cited by 17

Differences in the prevalence of prediabetes, undiagnosed diabetes and diagnosed diabetes and associated factors in cohorts of Brazilian and English older adults

dos Santos, E. S. M., Máximo, R. D. O., de Andrade, F. B., de Oliveira, C. M., Lima‐Costa, M. F., & Alexandre, T. D. S. (2020) · Public Health Nutrition · doi:10.1017/s1368980020003201 · Cited by 16

(Pre)diabetes, glycemia, and daily glucose variability are associated with retinal nerve fiber layer thickness in The Maastricht Study

van der Heide, F. C. T., Foreman, Y. D., Franken, I., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J., Webers, C. A. B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22748-2 · Cited by 16

The relationship between retinal nerve fiber layer thickness and carotid intima media thickness in patients with type 2 diabetes mellitus

Şahin, S. B., Şahin, O. Z., Ayaz, T., Karadağ, Z., Türkyılmaz, K., Aktaş, E., & Bostan, M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.010 · Cited by 16

Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes

Ramachandran, S., & Kartha, C. S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-038 · Cited by 16

Cardiovascular risk factors in confirmed prediabetic individuals. Haffner S M, Stern M P, Hazuda H P, et al. JAMA, 1990; 263: 2893–8

Shaw, K. M. (1990) · Practical Diabetes · doi:10.1002/pdi.1960070612

Cardiovascular Risk Factors in Patients With Prediabetes and its Relationship With Metabolic Syndrome

Topaloğlu, U. S. (2020) · Koşuyolu Heart Journal · doi:10.51645/khj.20075

The prediabetic problem: Development of non-insulin-dependent diabetes mellitus and related abnormalities

Haffner, S. M. (1997) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(96)00099-2 · Cited by 31

Parental history of diabetes is associated with increased cardiovascular risk factors.

Haffner, S. M., Stern, M. P., Hazuda, H. P., Mitchell, B. D., Patterson, J. K., & Ferrannini, E. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.928 · Cited by 88

Insulin resistance: The linchpin between prediabetes and cardiovascular disease

Salazar, M. R., Carbajal, H. A., Espeche, W. G., Aizpurúa, M., Sisnieguez, C. E. L., Sisnieguez, B. C. L., Stavile, R. N., March, C. E., & Reaven, G. M. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115610057 · Cited by 27